AI-assisted drug discovery is all the rage these days. It seems as if new companies and partnerships are being announced every day. Is this a new phenomenon, or an evolution of what has been done in the past? What are the key challenges standing in the way of computer-assisted drug discovery?
For the last episode of season 2 of the analytical wavelength we talk with two experts in drug discovery. Dr. Chris Lipinski is famous for introducing the "Lipinski Rule of 5s," the original prediction tool in drug discovery, which he developed at Pfizer. Dr. Olivier Elemento is a professor at Cornell University, where he studies AI-assisted drug discovery
More information about Percepta: https://www.acdlabs.com/products/percepta/index.php
Hosts:
Jesse Harris
Charis Lam
Brought to you by ACD/Labs: www.acdlabs.com